Mulligan SP, Thompson PA, Wight J, Anderson MA, et al. Real-world utilization of Bruton tyrosine kinase inhibitors in relapsed/refractory chronic lymphocytic leukemia in Australia. Leuk Lymphoma 2025 Jul 27:1-11. doi: 10.1080/10428194.2025.2533498.
PMID: 40716050